老年心脏病学杂志（英文版）2019，Vol.16Issue(3)：251-258,8.DOI:10.11909/j.issn.1671-5411.2019.03.015
Does ‘super-responder’ patients to cardiac resynchronization therapy still have indications for neuro-hormonal antagonists? Evidence from long-term follow-up in a single center
Does ‘super-responder’ patients to cardiac resynchronization therapy still have indications for neuro-hormonal antagonists? Evidence from long-term follow-up in a single center
Yi-Ran HU 1Wei HUA 1Han JIN 1Min GU 1Xiao-Han FAN 1Hong-Xia NIU 1Li-gang DING 1Jing WANG 1Shu ZHANG1
作者信息
- 1. Cardiac Arrhythmia Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- 折叠
摘要
关键词
Cardiac resynchronization therapy/Heart failure/Super-responder/Optimal medical therapyKey words
Cardiac resynchronization therapy/Heart failure/Super-responder/Optimal medical therapy引用本文复制引用
Yi-Ran HU,Wei HUA,Han JIN,Min GU,Xiao-Han FAN,Hong-Xia NIU,Li-gang DING,Jing WANG,Shu ZHANG..Does ‘super-responder’ patients to cardiac resynchronization therapy still have indications for neuro-hormonal antagonists? Evidence from long-term follow-up in a single center[J].老年心脏病学杂志（英文版）,2019,16(3):251-258,8.
